Suppressing Liver Cancer via the VEGFR1 Receptor using De novo Ellagic Acid Derivatives and Co-drugs: Comprehensive In silico Biochemistry Research with ADMET, RMSD, Molecular Docking, and Molecular Dynamics Simulations
- DOI
- 10.2174/0115680266507814260929070719
- Published
- 2026-09-30
- Container
- Current Topics in Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.2174/0115680266507814260929070719,
title = {Suppressing Liver Cancer via the VEGFR1 Receptor using De novo Ellagic Acid Derivatives and Co-drugs: Comprehensive In silico Biochemistry Research with ADMET, RMSD, Molecular Docking, and Molecular Dynamics Simulations},
author = {Soykan Agar and Esra Acar and Ozan Aldemir and Erkan Gokoluk and Ghassan Issa and Jane Bogdanov},
year = {2026},
journal = {Current Topics in Medicinal Chemistry},
doi = {10.2174/0115680266507814260929070719},
url = {https://doi.org/10.2174/0115680266507814260929070719}
}RIS
TY - JOUR TI - Suppressing Liver Cancer via the VEGFR1 Receptor using De novo Ellagic Acid Derivatives and Co-drugs: Comprehensive In silico Biochemistry Research with ADMET, RMSD, Molecular Docking, and Molecular Dynamics Simulations AU - Soykan Agar AU - Esra Acar AU - Ozan Aldemir AU - Erkan Gokoluk AU - Ghassan Issa AU - Jane Bogdanov PY - 2026 JO - Current Topics in Medicinal Chemistry DO - 10.2174/0115680266507814260929070719 UR - https://doi.org/10.2174/0115680266507814260929070719 ER -
APA
Agar, S., Acar, E., Aldemir, O., Gokoluk, E., Issa, G., & Bogdanov, J. (2026). Suppressing Liver Cancer via the VEGFR1 Receptor using De novo Ellagic Acid Derivatives and Co-drugs: Comprehensive In silico Biochemistry Research with ADMET, RMSD, Molecular Docking, and Molecular Dynamics Simulations. Current Topics in Medicinal Chemistry. https://doi.org/10.2174/0115680266507814260929070719
Source records
- crossref · retrieved 2026-11-10T18:00:13.739Z